Further evidence on the interaction of muramyl dipeptide with the serotonergic system

International Journal of Immunopharmacology

Volumn 18, Issue 1, 1996, Pages 23-29

  Slansky J ^a   Kadlec, O ^a   Sevcik J ^a   Masek K ^a  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

Author keywords

muramyl dipeptide; serotonin; smooth muscle

Indexed keywords

ATROPINE; BEMESETRON; ISAMOLTANE; KETANSERIN; MURAMYL DIPEPTIDE; SEROTONIN; SEROTONIN RECEPTOR; TROPISETRON;

ANIMAL TISSUE; ARTICLE; CARP; FEMALE; IMMUNOPHARMACOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SMOOTH MUSCLE;

EID: 0037984904     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/0192-0561(95)00100-X     Document Type: Article

References (29)

1. Bobker, D. H. & Williams, J. T. (1990). Serotonin-mediated inhibitory postsynaptic potential in guinea-pig prepositus hypoglossi and feedback inhibition by serotonin. J. Physiol., Lond., 422, 447-462.
2. Briejer, M. R., Akkermans, L. M. A. & Schuurkes, J. A. J. (1995). Interactions of serotonin with multiple receptors and neurotransmitters in the guinea-pig isolated colon. Arch. Int. Pharmacodyn., 329, 121-133.
3. Dougherty, P. M. & Dafny, N. (1990). Muramyl dipeptide, a macrophage-derived cytokine, alters neuronal activity in hypothalamus and hippocampus but not in the raphe/periaqueductal grey of rats. J. Neuroimmun., 28, 201-208.
4. 3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves. Naunyn Schmiedebergs Arch. Pharmac., 324, 116-124.
5. Fillion, M. P., Prudhomme, N., Haour, F., Fillion, G., Bonnet, M., Lespinats, G., Mašek, K., Flegel, M., Corvaia, N. & Launay, J. M. (1989). Hypothetical role of the serotonergic system in neuromodulation: preliminary molecular studies. In Interactions among Central Nervous System, Neuroendocrine and Immune Systems (eds Hadden, J. W., Mašek, K. and Nistico, G.), pp. 235-250. Pythagora Press, Rome.
6. Fozard, J. R. (1984). Neuronal 5-HT receptors in the periphery. Neuropharmacology, 23, 1473-1486.
7. Fozard, J. R. (1987). 5-HT: the enigma variations. Trends pharmac. Sci., 8, 501-506.
8. Green, K. & Campbell, G. (1994). Nitric oxide formation is involved in vagal inhibition of the stomach of the trout (Salmo gairdneri). J. Auton. Nerv. Syst., 50, 221-229.
9. Hartig, P. R. & Lever, J. (1990). Serotonin receptors. In Quantitative Imaging. Neuroreceptors, Neurotransmitters, and Enzymes (eds Frost, J. J. and Wagner, H. N., Jr), pp. 153-165. Raven Press, New York.
10. Holmgren, S., Grove, D. J. & Nilsson, S. (1985). Substance P acts by releasing 5-hydroxytryptamine from enteric neurons in the stomach of the rainbow trout, Salmo gairdneri. Neuroscience, 14, 683-693.
11. 1D receptors. Ann. N.Y. Acad. Sci., 600, 168-182.
12. Kadlec, O., Mašek, K., Gulda, O., Růžička, V., Parant, M. & Chedid, L. (1984). Smooth muscle stimulation by an immunomodulatory compound muramyl dipeptide: does it involve serotonergic system? Pharmacology, 29, 31-39.
13. Kadlec, O., Mašek, K. & Zídek, Z. (1986). The influence of immune status on the "in vitro" sensitivity of serotonergic receptors in the rat stomach strip. Meth. Find. Clin. Pharmac., 8, 127-129.
14. Kadlecová, O., Mašek, K., Seifert, J. & Petrovický, P. (1987). The involvement of some brain structures in the effect of immunomodulators. Ann. N.Y. Acad. Sci., 496, 394-398.
15. Karnovsky, M. L. (1986). Muramyl peptides in mammalian tissues and their effects at the cellular level. Fedn Proc., 45, 2556-2560.
16. Kitazawa, T. (1989). 5-Hydroxytryptamine is a possible neurotransmitter of the non-cholinergic excitatory nerves in the longitudinal muscle of rainbow trout stomach (Salmo gairdneri). Br. J. Pharmac., 98, 781-790.
17. Kitazawa, T., Kudo, K., Ishigami, M., Furuhashi, H., Temma, K. & Kondo, H. (1988). Evidence that a substance P-like peptide mediates the non-cholinergic excitatory response of the carp intestinal bulb (Cyprinus carpio). Naunyn Schmiedebergs Arch. Pharmac., 338, 68-73.
18. Martin, G. R. & Humphrey, P. P. A. (1994). Classification review. Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature. Neuropharmacology, 33, 261-273.
19. Mašek, K. (1986). Immunopharmacology of muramylpeptides. Fedn Proc., 45, 2549-2551.
20. Mašek, K. (1992). Current status and problems in preclinical assessment of immunomodulators. Dev. Biol. Standard, 77, 103-109.
21. Mašek, K., Horák, P., Kadlec, O. & Flegel, M. (1989). The interactions between neuroendocrine and immune systems at the receptors level. The possible role of serotonergic system. In Interactions among Central Nervous System, Neuroendocrine and Immune Systems (eds Hadden, J. W., Mašek, K. and Nistico, G.), pp. 225-234. Pythagora Press, Rome.
22. Mašek, K., Petrovický, P. & Seifert, J. (1992). An introduction to the possible role of central nervous system structures in neuroendocrine-immune systems interaction. Int. J. Immunopharmac., 14, 317-322.
23. Ogawa, T., Kotani, S., Tsujimoto, M., Kusumoto, S., Shiba, T., Kawata, S. & Yokogawa, K. (1983). Contractile effects of bacterial cell walls, their enzymatic digests and muramyl dipeptide on ileal strips from guinea-pigs. Infect. Immun., 35, 612-619.
24. Polanski, M. & Karnovsky, M. L. (1992). Serotonergic aspects of the response of human platelets to immune-adjuvant muramyl dipeptide. J. Neuroimmun., 37, 14-160.
25. Root-Bernstein, R. S. & Westall, F. C. (1990). Serotonin binding sites II. Muramyl dipeptide binds on myelin basic protein, LHRH, and MSH-ACTH 4-10. Brain Res. Bull., 25, 827-841.
26. Silverman, D. H. S., Imam, K. & Karnovsky, M. L. (1989). Muramylpeptide/serotonin receptors in brain-derived preparations. Peptide Res., 2, 338-344.
27. Silverman, D. H. S., Wu, H. & Karnovsky, M. L. (1985). Muramyl peptides and serotonin interact at specific binding sites on macrophages and enhance superoxide release. Biochem. biophys. Res. Commun., 131, 1161-1167.
28. Slánský, J., Kadlec, O., Mašek, K. & Gulda, O. (1994). The effect of immunomodulator muramyl dipeptide (MDP) on serotoninergic response of isolated neuromuscular preparations. Pharmacology, 48, 11-20.
29. 3 receptor antagonists on 5-HT and nicotinic depolarizations in guinea-pig submucosal neurones. Br. J. Pharmac., 99, 840-844.